Company / Working Capital
Traws Pharma, Inc. Working Capital History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$3.2M
FY2024
5-year range
-$3.2M / $49.3M
FY2020-FY2024
Trend
-123.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has declined for 3 consecutive years, from $49M in FY2021 to -$3M in FY2024.
Based on SEC 10-K filings.
-$3M in FY2024.
Declined from $31M to -$3M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Traws Pharma, Inc.'s working capital has declined for 3 consecutive years.
- In FY2024, working capital decreased 123.6% year-over-year.
- Peak working capital was recorded in FY2021.
- Lowest working capital in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$3.2M | -123.6% |
| FY2023 | $13.4M | -57.1% |
| FY2022 | $31.3M | -36.5% |
| FY2021 | $49.3M | +405.1% |
| FY2020 | $9.8M | -35.7% |
| FY2019 | $15.2M | +62.8% |
| FY2018 | $9.3M | +283.9% |
| FY2017 | -$5.1M | -139.3% |
| FY2016 | $12.9M | -17.1% |
| FY2015 | $15.6M | -57.5% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026